Table 1. General and clinical characteristics of patients with confirmed COVID-19 who were hospitalized in health facilities in Lima, Peru. March to October 2020.
| Factors | Total N=51,503 | Age groups | p-value a | ||
|---|---|---|---|---|---|
| Young (18-29) | Adults (30-59) | Older adults (≥60) | |||
| n=2366 (4.6%) | n=23,781 (46.2%) | n=25,356 (49.2%) | |||
| n (%) | n (%) | n (%) | n (%) | ||
| Sex | <0.001 | ||||
| Male | 31,104 (60.4) | 939 (39.7) | 15,099 (63.5) | 15,066 (59.4) | |
| Female | 20,399 (39.6) | 1427 (60.3) | 8682 (36.5) | 10,290 (40.6) | |
| Healthcare worker | <0.001 | ||||
| No | 46,601 (90.5) | 2132 (90.1) | 21,144 (88.9) | 23,325 (92.0) | |
| Yes | 4902 (9.5) | 234 (9.9) | 2637 (11.1) | 2031 (8.0) | |
| Comorbidities | 15,026 (29.2) | 208 (8.8) | 5219 (21.9) | 9599 (37.9) | <0.001 |
| Obesity | 2649 (5.1) | 95 (4.0) | 1570 (6.6) | 984 (3.9) | <0.001 |
| Diabetes | 5737 (11.1) | 30 (1.3) | 1944 (8.2) | 3763 (14.8) | <0.001 |
| Cardiovascular disease | 8059 (15.6) | 26 (1.1) | 1814 (7.6) | 6219 (24.5) | <0.001 |
| Chronic neurological disease | 536 (1.0) | 12 (0.5) | 138 (0.6) | 386 (1.5) | <0.001 |
| Kidney disease | 1144 (2.2) | 19 (0.8) | 324 (1.4) | 801 (3.2) | <0.001 |
| Chronic pulmonary disease | 847 (1.6) | 16 (0.7) | 244 (1.03) | 587 (2.3) | <0.001 |
| Asthma | 637 (1.2) | 31 (1.3) | 351 (1.5) | 255 (1.0) | 0.001 |
| Liver disease | 279 (0.5) | 6 (0.3) | 89 (0.4) | 184 (0.7) | <0.001 |
| Immunodeficiency | 157 (0.3) | 8 (0.3) | 98 (0.4) | 51 (0.2) | 0.004 |
| Cancer | 757 (1.5) | 15 (0.6) | 243 (1.0) | 499 (2.0) | <0.001 |
| Type of health establishment | <0.001 | ||||
| MINSA | 20,353 (39.5) | 1471 (62.2) | 9584 (40.3) | 9298 (36.7) | |
| EsSalud | 20,830 (40.4) | 454 (19.2) | 8260 (34.7) | 12,116 (47.8) | |
| FFAA/PNP | 3368 (6.6) | 122 (5.1) | 1649 (7.0) | 1597 (6.3) | |
| Private | 6952 (13.5) | 319 (13.5) | 4288 (18.0) | 2345 (9.2) | |
| Admission to ICU | 3403 (6.6) | 58 (2.5) | 1748 (7.4) | 1597 (6.3) | <0.001 |
| Use of mechanical ventilation | 4073 (7.9) | 83 (3.5) | 2152 (9.1) | 1838 (7.2) | <0.001 |
| Infection period | <0.001 | ||||
| March/April, 2020 | 5911 (11.5) | 204 (8.6) | 3072 (12.9) | 2635 (10.4) | |
| June/July, 2020 | 19,580 (38.0) | 899 (38.0) | 9033 (38.0) | 9648 (38.0) | |
| August/September, 2020 | 19,027 (36.9) | 816 (34.5) | 8688 (36.5) | 9523 (37.6) | |
| October/November, 2020 | 6985 (13.6) | 447 (18.9) | 2988 (12.6) | 3550 (14.0) | |
| Deceased | 22,787 (44.2) | 200 (8.5) | 6445 (27.1) | 16,142 (63.7) | <0.001 |
a
p-value calculated with the chi-square test.
MINSA: Ministry of Health; EsSalud: Peruvian Social Health Insurance; FFAA/PNP: Armed Forces and National Police; ICU: intensive care unit.